Alzheimer's disease (AD) is a neurodegenerative disease that causes progressive memory loss and a significant decline in ...

Scientists reverse Alzheimer's memory loss in mice by using NAD+ to restore brain energy, defying decades of research.

Specialized brain cells in the hypothalamus act as a disposal route for tau protein, shuttling it from cerebrospinal fluid into the bloodstream. When those cells break down, tau accumulates in the ...

A single treatment of viral vector-delivered CAR-A construct in mice with existing plaque saturation cut the amount of amyloid plaques in half.

Novel and potent catalytic approach that directly clears amyloid on the inside of neurons as well as reduces amyloid plaques with the potential ...

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s ...

Studies in rodents and humans suggest that low levels of the metal contribute to cognitive decline. “This is groundbreaking,” says Ashley Bush, a neuroscientist at the University of Melbourne in ...

Scientists are working hard to find better ways to treat Alzheimer’s disease, one of the most common causes of memory loss and dementia around the world. A new study from researchers at the University ...

Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in ...

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the ...

Genetically altered astrocytes that express chimeric antigen receptors offer a promising immunotherapy system capable of clearing accumulations of ...

A team of American scientists claim they have done something miraculous: they “cured” lab mice suffering from Alzheimer’s disease, which has robbed more than seven million Americans, typically 65 ...